Although considerable progress has been made in research and treatments in Motor Neuron Disease (MND) and associated neurodegenerative diseases (Alzheimer’s disease, Parkinson’s disease and Multiple sclerosis), the field has become wide-open with the recent advances in high throughput technologies in genomics, proteomics, metabolomics and Microbiomics, which have changed our perspective on the way these diseases have been looked at previously. Together, these technologies, which are the integral part of our approach, provide a renewed hope for a holistic visualization of these diseases that will help individuals of all ages afflicted with these diseases and define a new generation of diagnostics, prognostics and therapeutic modalities.

We are relentlessly committed to helping solve the mystery of these diseases.